Aldoketoreductase Family 1B10 (AKR1B10) Is a Sensitive Biomarker to Identify Well-Differentiated Hepatocellular Carcinoma

被引：0
|
作者：
Bandy, Andrew [1 ]
You, Xiaoming [1 ]
Li, Haonan [1 ]
Liao, Jie [1 ]
Rao, Sambasiva [1 ]
Lin, Xiaoqi [1 ]
Yang, Guang-Yu [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1635
引用
收藏
页码：414A / 414A
页数：1
相关论文
共 50 条
  • [41] EXPLORING THE ROLE OF AKR1B10 UPREGULATION IN HUMAN NASH
    Rady, Brian
    HEPATOLOGY, 2020, 72 : 326A - 327A
  • [42] Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma
    Wu, Tiangen
    Ke, Yang
    Tang, Haoran
    Liao, Chen
    Li, Jinze
    Wang, Lin
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 23 : 420 - 431
  • [43] AKR1B10 Is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Zheng, Linmao
    Zhang, Xingming
    Pan, Xiuyi
    Huang, Zhuo
    Zhang, Mengxin
    Xian, Jie
    Wei, Yuyan
    Nie, Ling
    Zhang, Mengni
    Gong, Jing
    Chen, Xueqin
    Zhou, Qiao
    Zeng, Hao
    Chen, Ni
    MODERN PATHOLOGY, 2023, 36 (11)
  • [44] AKR1B10 is a New Sensitive and Specific Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Zheng, Linmao
    Zhang, Xingming
    Pan, Xiuyi
    Zhou, Qiao
    Zeng, Hao
    Chen, Ni
    LABORATORY INVESTIGATION, 2023, 103 (03) : S840 - S841
  • [45] Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks
    Banerjee, Sreeparna
    CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE, 2021, 1347 : 65 - 82
  • [46] Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
    Murata, Ayato
    Genda, Takuya
    Ichida, Takafumi
    Amano, Nozomi
    Sato, Sho
    Tsuzura, Hironori
    Sato, Shunsuke
    Narita, Yutaka
    Kanemitsu, Yoshio
    Shimada, Yuji
    Hirano, Katsuharu
    Iijima, Katsuyori
    Wada, Ryo
    Nagahara, Akihito
    Watanabe, Sumio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (33) : 7569 - 7578
  • [47] Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
    Ayato Murata
    Takuya Genda
    Takafumi Ichida
    Nozomi Amano
    Sho Sato
    Hironori Tsuzura
    Shunsuke Sato
    Yutaka Narita
    Yoshio Kanemitsu
    Yuji Shimada
    Katsuharu Hirano
    Katsuyori Iijima
    Ryo Wada
    Akihito Nagahara
    Sumio Watanabe
    World Journal of Gastroenterology, 2016, (33) : 7569 - 7578
  • [48] Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer
    Taskoparan, Betul
    Seza, Esin Gulce
    Demirkol, Secil
    Tuncer, Sinem
    Stefek, Milan
    Gure, Ali Osmay
    Banerjee, Sreeparna
    CELLULAR ONCOLOGY, 2017, 40 (06) : 563 - 578
  • [49] AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy
    Shaw, Nicholas
    Yang, Bingmei
    Millward, Ann
    Demaine, Andrew
    Hodgkinson, Andrea
    CELL STRESS & CHAPERONES, 2014, 19 (02): : 281 - 287
  • [50] Prognostic significance of AKR1B10 gene expression in hepatocellular carcinoma and surrounding non-tumorous liver tissue
    Sonohara, Fuminori
    Inokawa, Yoshikuni
    Hishida, Mitsuhiro
    Kanda, Mitsuro
    Nishikawa, Yoko
    Yamada, Suguru
    Fujii, Tsutomu
    Sugimoto, Hiroyuki
    Kodera, Yasuhiro
    Nomoto, Shuji
    ONCOLOGY LETTERS, 2016, 12 (06) : 4821 - 4828
12345